Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically distinct, orally active, and highly potent small ...

Phil Lambert, Ph.D., chief scientific officer of Satellos Bioscience Inc., explains the mechanism of action of the company's experimental Duchenne muscular dystrophy drug, SAT-3247, and the thinking ...

Satellos Bioscience's experimental small-molecule drug for Duchenne muscular dystrophy is showing positive results as a stand-alone treatment, but Phil Lambert, Ph.D., the company's chief scientific ...

Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that ...

Researchers from Peking Union Medical College Hospital and artificial intelligence (AI) drug developer Insilico Medicine published phase 2a clinical trial data for a small-molecule treatment for ...

Kairos Pharma (NYSE American: KAPA) presented new preclinical data at the ASCO 2025 Annual Meeting on its investigational small molecule GITR ligand ...

Traws Pharma, Inc. (NASDAQ: TRAW) ("Traws Pharma”, "Traws” or "the Company”), a clinical-stage biopharmaceutical company ...

The prefilled syringe drug molecule market has seen significant evolution as healthcare systems globally strive for safer, more efficient drug delivery methods. Prefilled syringes offer an innovative ...

Michelin will invest over $60 million to construct a demonstration plant for a bio-sourced, non-toxic molecule—a molecule ...

Kymera Therapeutics Inc. (NASDAQ:KYMR) announced positive first-in-human results from its Phase 1 healthy volunteer clinical ...

The Kobe University discovery of this three-way relationship not only adds a new perspective to how plants interact with ...